Paragon Financial Partners’s AbbVie ABBV Stock Holding History

Paragon Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$451K	Buy	1,798 +1	+0.1%	+$215	0.24%	54
2026 Q1	$378K	Hold	1,797	–	–	0.21%	58
2025 Q4	$410K	Buy	1,797 +1	+0.1%	+$228	0.25%	53
2025 Q3	$416K	Buy	1,796 +1	+0.1%	+$204	0.26%	50
2025 Q2	$333K	Hold	1,795	–	–	0.23%	57
2025 Q1	$376K	Buy	1,795 +1	+0.1%	+$194	0.29%	50
2024 Q4	$319K	Sell	1,794 -3,059	-63%	-$562K	0.24%	57
2024 Q3	$958K	Buy	4,853 +1	+0%	+$187	0.7%	28
2024 Q2	$832K	Hold	4,852	–	–	0.65%	27
2024 Q1	$883K	Buy	4,852 +1	+0%	+$172	0.73%	25
2023 Q4	$752K	Sell	4,851 -256	-5%	-$37.3K	0.72%	23
2023 Q3	$761K	Hold	5,107	–	–	0.79%	22
2023 Q2	$688K	Buy	5,107 +1	+0%	+$147	0.65%	26
2023 Q1	$814K	Buy	5,106 +8	+0.2%	+$1.22K	0.85%	21
2022 Q4	$824K	Buy	5,098 +1,846	+57%	+$283K	0.91%	21
2022 Q3	$437K	Sell	3,252 -926	-22%	-$133K	0.49%	35
2022 Q2	$640K	Buy	4,178 +50	+1%	+$7.64K	0.66%	26
2022 Q1	$669K	Hold	4,128	–	–	0.58%	30
2021 Q4	$559K	Buy	+4,128	New	+$488K	0.46%	44

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Paragon Financial Partners's ABBV Position: Q2 2026 in Review

Paragon Financial Partners increased its AbbVie (ABBV) stake by 0.06% in Q2 2026, buying an estimated $215 and bringing the position to 1,798 shares worth $451K. The position accounts for 0.24% of the portfolio, ranked #54.

Paragon Financial Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $958K in Q3 2024. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Paragon Financial Partners held 1,798 shares of AbbVie worth $451K as of Q2 2026.
Paragon Financial Partners bought 1 AbbVie share in Q2 2026, an estimated $215.
AbbVie made up 0.24% of Paragon Financial Partners's portfolio in Q2 2026, its #54 holding.
Paragon Financial Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
Paragon Financial Partners's AbbVie position peaked at $958K in Q3 2024.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Paragon Financial Partners's 13F filing for Q2 2026, filed 7 Aug 2026.